Respective leaders in fermentation science and DAO-based medical nutrition join together to focus on innovative enzyme-based solutions for the human nutrition & health market.
PETERBOROUGH, U.K. 26 may 2021 – AB Biotek, a global business division of Associated British Foods plc – today announces that it has acquired DR Healthcare, a biomedical company focused on the dietary management of chronic diseases based in Barcelona, Spain.
This acquisition enables AB Biotek to boost its growing portfolio of differentiated microbiome modulating solutions for human nutrition and health. The acquisition adds diamine oxidase (DAO), an important intestinal enzyme, that will expand AB Biotek’s already strong commercial portfolio of probiotic yeast strains.
DAO, naturally secreted by the human body, is widely known as a critical enzyme at the core of reducing symptoms of many of today’s ailments, including migraine, food intolerances and attention deficit hyperactivity disorder, prevalent in millions of people around the world.
Juanjo Duelo, the founder of DR Healthcare, will remain with the business.
“With the acquisition of DR Healthcare, we now have the next stepping stone in shaping our science-based organization to serve the fast-growing human nutrition and health space,” said Gerald Dard, global managing director, AB Biotek. “DR Healthcare has a strong track record in this area, and we welcome our new colleagues who are equally passionate about the health and wellness of today’s consumers.”
“I am very excited about this new chapter as our companies have many shared values, from advanced health solutions and deep science to an extreme passion for what we do,” said Juanjo Duelo. “The future is bright under the good ownership of AB Biotek, and the timing is perfect to bring new, innovative technologies to improve the wellbeing of those people who suffer from various pathologies associated with the deficiency of DAO.”
About AB Biotek
AB Biotek contributes to the success of customers through the delivery of customized fermentation-based, sustainable solutions containing proprietary and/or purposefully sourced microorganisms to created differentiated food, beverage, health & nutrition business opportunities. Science and advanced microorganism fermentation technology are core enablers. AB Biotek has commercial scale production and research development facilities located around the world. For more information about our product applications and unmatched technical service capabilities, please visit www.abbiotek.com.
About DR Healthcare
Founded in Barcelona, Spain, in 2007, DR Healthcare is a biomedical company specialized in medical nutrition and dedicated to the research, development, innovation, marketing and licensing of new nutraceuticals, functional foods, active ingredients and customized solutions. Our medical nutrition products are aimed at dietary management of chronic diseases, physiological dysfunctions and/or metabolic diseases, mainly associated with metabolic disorders caused by a deficiency of the intestinal enzyme diamine oxidase (DAO). DR Healthcare produces DAO for both human and animal use and offers proprietary solutions for the food, pharmaceutical, veterinary and animal health industries. More information is available at www.dr-healthcare.com/en.
Patrick Barry +1.314.540.3865
Tina Díaz email@example.com
Míriam Cusí firstname.lastname@example.org
Cristina Vilà email@example.com
The Coronavirus has altered our lives. And it will also alter this Christmas, which will undoubtedly be different. Still, some things are not going to change compared to the Christmas holidays of other years: emotions increase, alcohol is exceeded, meals are exaggerated and, consequently, many people will have heavy digestion, flatulence, a feeling of bloating, contractures, hangover, headache and even migraine.
Histamine in Christmas foods
And it is not only COVID-19 alters Christmas. A molecule present in most “Christmas” foods is related with all these symptoms and also alters our lives. Is the histamine, a molecule necessary for life but that in excess becomes “perverse”. An amine that is especially present and abundant in the foods consumed at Christmas parties: by tradition, Christmas is accompanied by certain foods with a high concentration of histamine such as canapes, appetizers with sausages, smoked meats, assorted sauces such as the bechamel of the cannelloni or the tartar sauce of the fish; seafood, canned foods such as anchovies, spices such as curry or cinnamon, nougats, polvorones or roscón de reyes, cava, champagne and other alcoholic beverages.
DAO enzyme to avoid its effects
The Diamine Oxidase or DAO enzyme is responsible for metabolizing or degrading the histamine ingested through these foods. However, in these days of dietary excesses DAO activity is saturated or even inhibited by alcohol, so our best recommendation is to prevent the appearance of these symptoms by previously supplementing Christmas menus with DAO enzyme.
This measure is also advisable for those people who spend Christmas at home having tested positive for their last coronavirus test. Published studies indicate that SAR COV-2 infection causes a release of cytokines from mast cells, accompanied by a release of endogenous histamine, which may justify the triggering of some of the symptoms, so it is advisable to control the entry routes of dietary histamine or guarantee its degradation by taking DAO preventively to avoid further accumulation in plasma.
Our DAO products
DAOfood® and DAOfood® Plus are biological DAO enzyme supplements that increase the degradation capacity of dietary histamine. Its intake prevents the absorption and accumulation of circulating histamine and also counteracts the release of endogenous histamine as a reaction of the body when it comes into contact with the virus.
DR Healthcare wishes you a Happy Holidays!
Kritas, S. K., Ronconi, G., Caraffa, A., Gallenga, C. E., Ross, R., & Conti, P. (2020). Mast cells contribute to coronavirus-induced inflammation: new anti-inflammatory strategy. Journal of biological regulators and homeostatic agents, 34(1), 10.23812/20-Editorial-Kritas.